Award
National Heart, Lung, and Blood Institute 5K99HL181079-02
Platelets as therapeutic and diagnostic entity in fibromuscular dysplasia
Recipient
Cleveland Clinic Lerner COM-CWRU
Award Amount
$118,919.00
Ceiling
$118,919.00
Awarded
June 01, 2026
Identifier
5K99HL181079-02
NIH grant awarded by the National Heart Lung and Blood Institute to Cleveland Clinic Lerner COM-CWRU for research on fibromuscular dysplasia, focusing on diagnostics and therapeutics, with an award amount of approximately $118,919 for fiscal year 2026.
Description
The project focuses on fibromuscular dysplasia (FMD), a vascular disease affecting women, with an emphasis on biomarkers, stroke risk prediction, and therapeutic interventions. The project aims to develop blood-based diagnostic tests and explore mitochondrial dysfunction in FMD. The project duration is from August 1, 2025, to June 30, 2027.